Cargando…
Gastric perforation related to concurrent use of nintedanib and ramucirumab
The prevalence of lung cancer in idiopathic pulmonary fibrosis (IPF) patients ranges from 9.8 to 38%. Nintedanib, a small molecule receptor tyrosine kinase inhibitor (TKI) of platelet‐derived growth factor receptor (PDGFR), fibroblast growth factor receptor (FGFR), and vascular endothelial growth fa...
Autores principales: | Takahashi, Saeko, Murata, Saori, Yoshino, Yudai, Kobayashi, Yosuke, Nakamura, Morio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6223100/ https://www.ncbi.nlm.nih.gov/pubmed/30455955 http://dx.doi.org/10.1002/rcr2.383 |
Ejemplares similares
-
A case of ramucirumab-related gastrointestinal perforation in gastric cancer with small bowel metastasis
por: Urakawa, Shinya, et al.
Publicado: (2017) -
A case of central neurogenic hyperventilation without tachypnoea
por: Murata, Saori, et al.
Publicado: (2019) -
The first case of micropapillary adenocarcinoma associated with cystic airspace in a non‐smoking man
por: Takahashi, Saeko, et al.
Publicado: (2019) -
Endoscopic Ultrasound-Guided Drainage of Intra-Abdominal Abscess after Gastric Perforation in a Patient Receiving Ramucirumab and Paclitaxel for Advanced Gastric Cancer
por: Mandai, Koichiro, et al.
Publicado: (2017) -
Delayed Healing of Tooth Extraction Sockets with Ramucirumab Use
por: Iijima, Yosuke, et al.
Publicado: (2020)